2 results about "Chronic eczema" patented technology

The application belongs to the technical field of traditional Chinese medicine compositions, and particularly relates to a traditional Chinese medicine compound preparation for treating anal eczema as well as a preparation method and application thereof. The traditional Chinese medicine compound preparation is prepared from the following raw medicinal materials in parts by weight: 35-45 parts of Sophora flavescens, 35-45 parts of Cnidium monnieri, 18-22 parts of Semen Astragali Complanati, 18-22 parts of Cortex Dictamni, 18-22 parts of Scutellaria baicalensis, 118-22 parts of Phellodendri, 10-14 parts of Chuanxiong Rhizoma, 16-20 parts of Angelica sinensis, 10-14 parts of Radix Paeoniae Alba, 16-20 parts of Saposhnikovia divaricata, and 10-14 parts of Gleditsia sinensis. The application provides a traditional Chinese medicine compound preparation and a Chinese medicine treatment method for treating acute and chronic anal eczema caused by 'damp-heat invasion'. The traditional Chinese medicine compound preparation can not only significantly relieve the perianal pruritus and exudation of the patients with anal eczema, but also effectively reduce the skin lesion area and improve the skin lesion state, and the clinical curative effect is obvious. In addition, the raw materials of the traditional Chinese medicine compound preparation are widely sourced and low in price, the pure traditional Chinese medicine raw materials are used for processing, and the preparation process is simple.

This invention relates to the field of pharmaceutical technology, specifically disclosing a polypeptide extracted from the traditional Chinese medicine Artemisia argyi, the amino acid sequence of which is shown in SEQ ID No. 1. This polypeptide can be prepared from Artemisia argyi through steps such as ultrasonic disruption, enzymatic hydrolysis, and purification. Experiments show that the Artemisia argyi polypeptide at a concentration of 2 μg / mL inhibits Staphylococcus aureus by 92±4.72%. This invention also provides a medicated bath component containing the Artemisia argyi polypeptide, which can significantly alleviate itching, lesion area, and morphology in patients with chronic eczema. After 30 days of treatment, the experimental group's score decreased from 7.8 to 3.1 (the control group showed no significant change). The polypeptide of this invention is naturally derived and highly safe, providing a new strategy for the treatment of eczema.